Multiple aspects of mineralocorticoid selectivity

American Journal of Physiology - Renal Physiology

Volumn 280, Issue 2 49-2, 2001, Pages

  Farman, Nicolette ^a   Rafestin Oblin, Marie Edith ^a  

^a INSERM   (France)

Author keywords

11 hydroxysteroid dehydrogenase; Aldosterone; Corticosteroid receptors; Glucocorticoid hormones; Kidney; Sodium transport

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; CORTICOSTEROID; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; SODIUM; STEROID; TRANSCRIPTION FACTOR;

ENZYME ACTIVATION; HORMONAL REGULATION; HORMONE METABOLISM; HORMONE RECEPTOR INTERACTION; HUMAN; KIDNEY TUBULE ABSORPTION; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; REVIEW; TARGET CELL; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

EID: 0035018870     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2001.280.2.f181     Document Type: Review

References (119)

1. Agarwal AK, Mune T, Monder C, and White PC. NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase - cloning and characterization of cDNA from sheep kidney. J Biol Chem 269: 25959-25962, 1994.
2. Albiston AL, Obeyesekere VR, Smith RE, and Krozowski ZS. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 105: 11-17, 1994.
3. Alfaidy N, Blot-Chabaud M, Bonvalet JP, and Farman N. Vasopressin potentiates mineralocorticoid selectivity by stimulating 11 beta hydroxysteroid dehydrogenase in rat collecting duct. J Clin Invest 100: 2437-2442, 1997.
4. Alfaidy N, Blot-Chabaud M, Robic D, Kenouch S, Bourbouze R, Bonvalet JP, and Farman N. Characteristics and regulation of 11 beta-hydroxysteroid dehydrogenase of proximal and distal nephron. Biochim Biophys Acta 1243: 461-468, 1995.
5. Arriza JL, Simerly RB, Swanson LW, and Evans RM. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron 1: 887-900, 1988.
6. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, and Evans RM. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237: 268-275, 1987.
7. + channel subunits. Am J Physiol Cell Physiol 271: C605-C611, 1996.
8. Attmane-Elakeb A, Amlal H, and Bichara M. Ammonium carriers in the medullary thick ascending limb. Am J Physiol Renal Physiol 279: F1169-F1177, 2000.
9. Bamberger CM, Bamberger AM; Wald M, Chrousos GP, and Schulte HM. Inhibition of mineralocorticoid activity by the beta-isoform of the human glucocorticoid receptor. J Steroid Biochem Mol Biol 60: 43-50, 1997.
10. +-ATPase by aldosterone in renal target cells: permissive effect of triidothyronine. Proc Natl Acad Sci USA 85: 1707-1711, 1988.
11. Barnett CA and Pritchett EL. Detection of corticosteroid type I binding sites in heart. Mol Cell Endocrinol 56: 191-198, 1988.
12. Bens M, Vallet V, Cluzeaud F, Pascual-Letallec L, Kahn A, Rafestin-Oblin ME, Rossier BC, and Vandewalle A. Corticosteroid-dependent sodium transport in a novel immortalized mouse collecting duct principal cell line. J Am Soc Nephrol 10: 923-934, 1999.
13. + metabolism. Proc Natl Acad Sci USA 95: 9424-9429, 1998.
14. Bleich M, Warth R, Schmidt-Hieber M, Schulz-Baldes A, Hasselblatt P, Fisch D, Berger S, Kunzelmann K, Kriz W, Schutz G, and Greger R. Rescue of the mineralocorticoid receptor knock-out mouse. Pflügers Arch 438: 245-254, 1999.
15. Bonvalet JP. Regulation of sodium transport by steroid hormones. Kidney Int 53: S49-S56, 1998.
16. Bonvalet JP, Doignon I, Blot-Chabaud M, Pradelles P, and Farman N. Distribution of 11beta-hydroxysteroid dehydrogenase along the rabbit nephron. J Clin Invest 86: 832-837, 1990.
17. Bourguet W, Ruff M, Chambon P, Gronemeyer H, and Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 375: 377-382, 1995.
18. Brown RW, Chapman KE, Kotelevtsev Y, Yau JLW, Lindsay RS, Brett L, Leckie C, Murad P, Lyons V, Mullins JJ, Edwards CRW, and Seckl JR. Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2. Biochem J 313: 1007-1017, 1996.
19. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, and Cariquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753-758, 1997.
20. Campen TJ, Vaughn DA, and Fanestil DD. Mineralo- and glucocorticoid effects on renal excretion of electrolytes. Pflügers Arch 399: 93-101, 1983.
21. Chen SY, Bhargava A, Mastroberardino L, Meijer OC, Wang J, Buse P, Firestone GL, Verrey F, and Pearce D. Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci USA 96: 2514-2519, 1999.
22. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, and Schutz G. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 9: 1608-1621, 1995.
23. Colligwood TN, Urnov FD, and Wolffe AP. Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J Mol Endocrinol 23: 255-275, 1999.
24. Couette B, Fagart J, Jalaguier S, Lombes M, Souque A, and Rafestin-Oblin ME. The ligand induced conformational change of the mineralocorticoid receptor occurs within its heterooligomeric structure. Biochem J 315: 421-427, 1996.
25. Crocoll A, Schneikert J, Hubner S, Martin E, and Cato ACB. BAG-1M: a potential specificity determinant of corticosteroid receptor action. Kidney Int 57: 1265-1269, 2000.
26. De Castro M, Elliot S, Kino T, Bamberger C, Karl M, Webster E, and Chrousos GP. The non-ligand binding beta-isoform of the human glucocorticoid receptor (hGR beta): tissue levels, mechanism of action, and potential physiologic role. Mol Med 2: 597-607, 1996.
27. De Kloet ER, Van Acker ABE, Sibug RM, Oitzl MS, Meijer OC, Rahmouni K, and de Jong W. Brain mineralocorticoid receptors and centrally regulated functions. Kidney Int 57: 1329-1336, 2000.
28. Djelidi S, Fay M, Cluzeaud F, Escoubet B, Eugene E, Capurro C, Bonvalet JP, Farman N, and Blot-Chabaud M. Transcriptional regulation of sodium transport by vasopressin in renal cells. J Biol Chem 272: 32919-32924, 1997.
29. Edwards CRW, Stewart PM, Burt D, Bret L, Mc Intyre MA, Sutanto WS, de Kloet ER, and Monder C. Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 2: 986-989, 1988.
30. Escoubet B, Coureau C, Blot-Chabaud M, Bonvalet JP, and Farman N. Corticosteroid receptor mRNA expression is unaffected by corticosteroids in rat kidney, heart, and colon. Am J Physiol Cell Physiol 270: C1343-C1353, 1996.
31. Escoubet B, Coureau C, Bonvalet JP, and Farman N. Noncoordinate regulation of epithelial Na channel and Na pump subunit mRNAs in kidney and colon by aldosterone. Am J Physiol Cell Physiol 272: C1482-C1491, 1997.
32. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 240: 889-895, 1988.
33. Fagart J, Wurtz JM, Souque A, Hellal-Levy C, Moras D, and Rafestin-Oblin ME. Antagonism in the human mineralocorticoid receptor. EMBO J 17: 3317-3325, 1998.
34. Farman N. Molecular and cellular determinants of mineralocorticoid selectivity. Curr Opin Nephrol Hypertens 8: 45-51, 1999.
35. Farman N and Bocchi B. Mineralocorticoid selectivity: molecular and cellular aspects. Kidney Int 57: 1364-1369, 2000.
36. Farman N and Bonvalet JP. Aldosterone binding in isolated tubules. III. Autoradiography along the rat nephron. Am J Physiol Renal Fluid Electrolyte Physiol 245: F606-F614, 1983.
37. +-ATPase α3-subunit mRNA expression in rat hippocampus. Am J Physiol Cell Physiol 266: C423-C428, 1994.
38. +-ATPase messenger RNA expression in rat distal nephron. Am J Physiol Cell Physiol 263: C810-C817, 1992.
39. Farman N, Oblin ME, Lombes M, Delahaye F, Westphal HM, Bonvalet JP, and Gasc JM. Immunolocalization of gluco- and mineralocorticoid receptors in the rabbit kidney. Am J Physiol Cell Physiol 260: C226-C233, 1991.
40. Farman N, Vandewalle A, and Bonvalet JP. Binding of aldosterone to cytoplasmic and nuclear receptors of the rabbit kidney. Am J Physiol Cell Physiol 240: C20-C27, 1981.
41. Farman N, Vandewalle A, and Bonvalet JP. Aldosterone binding in isolated tubules. II. An autoradiographic study of concentration dependency in the rabbit nephron. Am J Physiol Renal Fluid Electrolyte Physiol 242: F69-F77, 1982.
42. Farman N, Vandewalle A, and Bonvalet JP. Autoradiographic determination of dexamethasone binding sites along the rabbit nephron. Am J Physiol Renal Fluid Electrolyte Physiol 244: F325-F334, 1983.
43. Farman N, Vandewalle A, and Bonvalet JP. Aldosterone binding in isolated tubules. I. Biochemical determination in proximal and distal parts of the rabbit nephron. Am J Physiol Renal Fluid Electrolyte Physiol 242: F63-F68, 1982.
44. Fejes-Toth G, Pearce D, and Naray-Fejes-Toth A. Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists. Proc Natl Acad Sci USA 95: 2973-2978, 1998.
45. Fuller PJ, Lim-Tio SS, and Brennan F. Specificity in mineralocorticoid versus glucocorticoid action. Kidney Int 57: 1256-1264, 2000.
46. Funder JW. Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. Annu Rev Med 48: 231-240, 1997.
47. Funder JW, Pearce PT, Smith R, and Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242: 583-585, 1988.
48. Galigniana MD. Native rat kidney mineralocorticoid receptor is a phosphoprotein whose transformation to a DNA-binding form is induced by phosphatases. Biochem J 333: 555-563, 1998.
49. Garty H and Palmer LG. Epithelial sodium channels: function, structure, and regulation. Physiol Rev 77: 359-396, 1997.
50. Hawk CT, Li L, and Schafer JA. AVP and aldosterone at physiological concentrations have synergistic effects on Na transport in rat CCD. Kidney Int 50: S35-S41, 1996.
51. Hellal-Levy C, Couette C, Fagart J, Souque A, Gomes-Sanchez C, and Rafestin-Oblin ME. Specific hydroxylations determine selective corticosteroid recognition by human glucocorticoid and mineralocorticoid receptors. FEBS Lett 464: 9-13, 1999.
52. Hellal-Levy C, Fagart J, Souque A, and Rafestin-Oblin ME. Mechanistic aspects of mineralocorticoid receptor activation. Kidney Int 57: 1250-1255, 2000.
53. + excretion in the adrenalectomized rat. Am J Physiol Renal Fluid Electrolyte Physiol 245: F89-F99, 1983.
54. Johnson JP. Cellular mechanisms of action of mineralocorticoid hormones. Pharmacol Ther 53: 1-29, 1992.
55. Kenouch S, Alfaidy N, Bonvalet JP, and Farman N. Expression of 11 beta-OHSD along the nephron of mammals and humans. Steroids 59: 100-104, 1994.
56. Kenouch S, Coutry N, Farman N, and Bonvalet JP. Multiple patterns of 11β-hydroxysteroid dehydrogenase catalytic activity along the mammalian nephron. Kidney Int 42: 56-60, 1992.
57. Kenouch S, Lombes M, Delahaye F, Eugene E, Bonvalet JP, and Farman N. Human skin as target for aldosterone: coexpression of mineralocorticoid receptors and 11 beta-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab 79: 1334-1341, 1994.
58. Kotelevtsev Y, Brown RW, Fleming S, Kenyon C, Edwards CRW, Seckl JR, and Mullins AJ. Hypertension in mice lacking 11 beta-hydroxysteroid dehydrogenase type 2. J Clin Invest 103: 683-689, 1999.
59. Krozowski ZK and Funder JW. Renal mineralocorticoid receptors and hippocampal corticosterone binding series have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 80: 6056-6060, 1983.
60. Krozowski Z, Maguire JA, Steinoakley AN, Dowling J, Smith RE, and Andrews RK. Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J Clin Endocrinol Metab 80: 2203-2209, 1995.
61. + transport by rat collecting duct cells in culture - differences between glucocorticoid and mineralocorticoid hormones. J Clin Invest 90: 1370-1378, 1992.
62. Lim Tio SS and Fuller PJ. Intracellular signaling pathways confer specificity of transactivation by mineralocorticoid and glucocorticoid receptors. Endocrinology 139: 1653-1661, 1998.
63. Lim Tio SS, Keightley MC, and Fuller PJ. Determinants of specificity of transactivation by mineralocorticoid or glucocorticoid receptor. Endocrinology 138: 2537-2543, 1997.
64. Liu WH, Wang J, Sauter NK, and Pearce D. Steroid receptor heterodimerization demonstrated in vitro and in vivo. Proc Natl Acad Sci USA 92: 12480-12484, 1995.
65. Liu WH, Wang J, Yu GQ, and Pearce D. Steroid receptor transcriptional synergy is potentiated by disruption of the DNA-binding domain dimer interface. Mol Endocrinol 10: 1399-1406, 1996.
66. Lombes M, Alfaidy N, Eugene E, Lessana A, Farman N, and Bonvalet JP. Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase in the human heart. Circulation 92: 175-182, 1995.
67. Lombes M, Binart N, Delahaye F, Baulieu EE, and Rafestin-Oblin ME. Differential intracellular localization of human mineralocorticosteroid receptor on binding of agonists and antagonists. Biochem J 302: 191-197, 1994.
68. Lombes M, Farman N, Oblin ME, Baulieu EE, Bonvalet JP, Erlinger BP, and Gasc JM. Immunohistochemical localization of renal mineralocorticoid receptor by using an antiidiotypic antibody that is an internal image of aldosterone. Proc Natl Acad Sci USA 87: 1086-1088, 1990.
69. Lombes M, Kenouch S, Souque A, Farman N, and Rafestin-Oblin ME. The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11 beta-hydroxysteroid dehydrogenase. Endocrinology 135: 834-840, 1994.
70. Lombes M, Oblin ME, Gasc JM, Baulieu EE, Farman N, and Bonvalet JP. Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ Res 71: 503-510, 1992.
71. Lupo B, Mesnier D, and Auzou G. Cysteines 849 and 942 of human mineralocorticoid receptor are crucial for steroid binding. Biochemistry 37: 12153-12159, 1998.
72. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, and Evans RM. Overview: the nuclear receptor superfamily: the second decade. Cell 83: 835-839, 1995.
73. May A, Puoti A, Gaeggeler HP, Horisberger JD, and Rossier BC. Early effect of aldosterone on the rate of synthesis of the epithelial sodium channel alpha subunit in A6 renal cells. J Am Soc Nephrol 8: 1813-1822, 1997.
74. Mc Donnell DP, Shahbaz MM, Vegeto E, and Goldman ME. The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity. J Steroid Biochem Mol Biol 48: 425-432, 1994.
75. Mc Ewen BS, de Kloet ER, and Rostene W. Adrenal steroid receptors and actions in the nervous system. Physiol Rev 66: 1121-1188, 1986.
76. Modarress KJ, Opoku J, Xu M, Sarlis NJ, and Simons SS. Steroid-induced conformational changes at ends of the hormone-binding domain in the rat glucocorticoid receptor are independent of agonist versus antagonist activity. J Biol Chem 272: 23986-23994, 1997.
77. Moras D and Gronemeyer H. The nuclear receptor ligand-binding domain - structure and function. Curr Opin Cell Biol 10: 384-391, 1998.
78. Morris DJ, Souness GW, Brem AS, and Rafestin-Oblin ME. Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues. Kidney Int 57: 1370-1373, 2000.
79. Mune T and White PC. Apparent mineralocorticoid excess: genotype is correlated with biochemical phenotype. Hypertension 27: 1193-1199, 1996.
80. Naray-Fejes-Toth A, Canessa C., Cleaveland ES, Aldrich G, and Fejes-Toth G. Sgk is an aldosterone-induced kinase in the renal collecting duct: effects on epithelial Na channels. J Biol Chem 274: 16973-16978, 2000.
81. Naray-Fejes-Toth A and Fejes-Toth G. Glucocorticoid receptors mediate mineralocorticoid-like effects in cultured collecting duct cells. Am J Physiol Renal Fluid Electrolyte Physiol 259: F672-F678, 1990.
82. Naray-Fejes-Toth A, Watlington CO, and Fejes-Toth G. 11 Beta-hydroxysteroid dehydrogenase activity in the renal target cells of aldosterone. Endocrinology 129: 17-21, 1991.
83. Oakley RH, Sar M, and Cidlowski JA. The human glucocorticoid receptor beta isoform - expression, biochemical properties, and putative function. J Biol Chem 271: 9550-9559, 1996.
84. O'Neil RG and Helman SI. Transport characteristics of renal collecting tubules: influences of DOCA and diet. Am J Physiol Renal Fluid Electrolyte Physiol 233: F544-F558, 1977.
85. Oppermann UCT, Persson B, and Jornvall H. The 11-beta-hydroxysteroid dehydrogenase system, a determinant of glucocorticoid and mineralocorticoid action - function, gene organization and protein structures of 11-beta-hydroxysteroid dehydrogenase isoforms. Eur J Biochem 249: 355-360, 1997.
86. Palmer LG and Frindt G. Aldosterone and potassium secretion by the cortical collecting duct. Kidney Int 57: 1324-1328, 2000.
87. Pearce D and Yamamoto KR. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 259: 1161-1165, 1993.
88. Pearce P and Funder JW. High affinity aldosterone binding sites (type I receptors) in rat heart. Clin Exp Pharmacol Physiol 14: 859-866, 1987.
89. Quinkler M, Johanssen S, Grossmann C, Bahr V, Muller M, Oelkers W, and Diederich S. Progesterone metabolism in the human kidney and inhibition of 11 β-hydroxysteroid dehydrogenase type 2 by progesterone and its metabolites. J Clin Endocrinol Metab 84: 4165-4171, 1999.
90. Rafestin-Oblin ME, Lombes M, Couette B, and Baulieu EE. Differences between aldosterone and its antagonists in binding kinetics and ligand-induced hsp90 release from mineralocorticosteroid receptor. J Steroid Biochem Mol Biol 41: 815-821, 1992.
91. Ray DW, Suen CS, Brass A, Soden J, and White A. Structure/function of the human glucocorticoid receptor: tyrosine 735 is important for transactivation. Mol Endocrinol 13: 1855-1863, 1999.
92. + channel in colon, lung and kidney. Pflügers Arch 430: 299-307, 1995.
93. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, and Moras D. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378: 681-689, 1995.
94. Ribeiro RCJ, Kushner PJ, and Baxter JD. The nuclear hormone receptor gene superfamily. Annu Rev Med 46: 443-453, 1995.
95. Rogerson FM, Dimopoulos N, Sluka P, Chu S, Curtis AJ, and Fuller PJ. Structural determinants of aldosterone binding selectivity in the mineralocorticoid receptor. J Biol Chem 274: 36305-36311, 1999.
96. Roland BL, Krozowski ZS, and Funder JW. Glucocorticoid receptor, mineralocorticoid receptors, 11 beta-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies. Mol Cell Endocrinol 111: R1-R7, 1995.
97. Roux S, Terouanne B, Couette B, Rafestin-Oblin ME, and Nicolas JC. Conformational change in the human glucocorticoid receptor induced by ligand binding is altered by mutation of isoleucine 747 by a threonine. J Biol Chem 274: 10059-10065, 1999.
98. Rupprecht R, Arriza JL, Spengler D, Reul JMHM, Evans RM, Holsboer F, and Damm K. Transactivation and synergistic properties of the mineralocorticoid receptor relationship to the glucocorticoid receptor. Mol Endocrinol 7: 597-603, 1993.
99. Rusvai E and Naray-Fejes-Toth A. A new isoform of 11-beta-hydroxysteroid dehydrogenase in aldosterone target cells. J Biol Chem 268: 10717-10720, 1993.
100. + transport in A6 cells is mediated via glucocorticoid receptors. Am J Physiol Cell Physiol 264: C875-C884, 1993.
101. Schulman G, Robertson NM, Elfenbein IB, Eneanya D, Litwack G, and Bastl CP. Mineralocorticoid and glucocorticoid receptor steroid binding and localization in colonic cells. Am J Physiol Cell Physiol 266: C729-C740, 1994.
102. Scott BA, Lawrence B, Nguyen HH, and Meyer WJ. Aldosterone and dexamethasone binding in human arterial smooth muscle cells. J Hypertens 5: 739-744, 1987.
103. Seckl JR and Chapman KE. The 11-beta-hydroxysteroid dehydrogenase system, a determinant of glucocorticoid and mineralocorticoid action - medical and physiological aspects of the 11-beta-hydroxysteroid dehydrogenase system. Eur J Biochem 249: 361-364, 1997.
104. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, and Greene GL. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95: 927-937, 1998.
105. Silvestre JS, Robert V, and Delcayre C. The cardiac endocrine aldosterone system. Curr Opin Endocrinol Diabetes 6: 204-209, 1999.
106. Stanton BA. Regulation by adrenal corticosteroids of sodium and potassium transport in loop of Henle and distal tubule of rat kidney. J Clin Invest 78: 1612-1620, 1986.
107. Todd-Turla KM, Schnennann J, Fejes-Toth G, Naray. Fejes-Toth A, Smart A, Killen PD, and Briggs JP. Distribution of mineralocorticoid and glucocorticoid receptor messenger RNA along the nephron. Am J Physiol Renal Fluid Electrolyte Physiol 264: F781-F791, 1993.
108. Trapp T and Holsboer F. Ligand-induced conformational changes in the mineralocorticoid receptor analyzed by protease mapping. Biochem Biophys Res Commun 215: 286-291, 1995.
109. Trapp T and Holsboer F. Heterodimerization between mineralocorticoid and glucocorticoid receptors increases the functional diversity of corticosteroid action. Trends Pharmacol Sci 17: 145-149, 1996.
110. Trapp T, Rupprecht R, Castren M, Reul JMHM, and Holsboer F. Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS. Neuron 13: 1457-1462, 1994.
111. Tsai MJ and Omalley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63: 451-486, 1994.
112. Turnamian SG and Binder HJ. Regulation of active sodium and potassium transport in the distal colon of the rat. J Clin Invest 84: 1924-1929, 1989.
113. Uppenberg J, Svensson C, Jaki M, Bertilsson G, Jendeberg L, and Berkenstam A. Crystal structure of the ligand binding domain of the human nuclear receptor PPARgamma. J Biol Chem 273: 31108-31112, 1998.
114. Verrey F. Early aldosterone action: toward filling the gap between transcription and transport. Am J Physiol Renal Physiol 277: F319-F327, 1999.
115. Verrey F, Pearce D, Pfeiffer R, Spindler B, Mastroberardino L, Summa V, and Zecevic M. Pleitropic action of aldosterone in epithelia mediated by transcription and posttranscription mechanisms. Kidney Int 57: 1277-1282, 2000.
116. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, and Fletterick RJ. A structural role for hormone in the thyroid hormone receptor. Nature 378: 690-697, 1995.
117. Webster JC, Jewell CM, Bodwell JE, Munck A, Sar M, and Cidlowski JA. Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J Biol Chem 272: 9287-9293, 1997.
118. White PC, Mune T, and Agarwal AK. 11 Beta-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 18: 135-156, 1997.
119. Williams SP and Sigler PB. Atomic structure of progesterone complexed with its receptor. Nature 393: 392-396, 1998.